Safety and Efficacy Study of DuoTrav APS Versus DuoTrav
NCT00862472 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2012-01-18
Summary
The purpose of the study is to demonstrate that the IOP-lowering efficacy of DuoTrav APS, dosed once-daily in the morning, is non-inferior to that of DuoTrav, dosed once-daily in the morning.
Conditions
- Open-angle Glaucoma
- Ocular Hypertension
Interventions
- DRUG
-
DuoTrav APS
DuoTrav APS QD AM
- DRUG
-
DuoTrav
DuoTrav QD AM
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-06-30
- Completion
- 2009-06-30
More Related Trials
-
Safety and Efficacy of Changing to DuoTrav From Prior Therapy
NCT01230736 ·Status: COMPLETED ·Phase: PHASE4
-
Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
NCT01452009 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
NCT01514721 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
NCT02003391 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
NCT01336569 ·Status: COMPLETED ·Phase: PHASE4
-
A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma
NCT00887029 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
NCT00966940 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
NCT00637130 ·Status: COMPLETED ·Phase: PHASE2
-
Divided Dose of TRAVATAN®
NCT01298687 ·Status: COMPLETED ·Phase: PHASE2
-
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
NCT00519753 ·Status: COMPLETED ·Phase: PHASE4
-
Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
NCT00892762 ·Status: COMPLETED ·Phase: PHASE3
-
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00527501 ·Status: COMPLETED ·Phase: PHASE2
-
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
NCT00767494 ·Status: TERMINATED ·Phase: PHASE3
-
Travoprost 3-Month Safety and Efficacy Study
NCT01453855 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
NCT00471068 ·Status: TERMINATED ·Phase: PHASE4
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT00051142 ·Status: COMPLETED ·Phase: PHASE3
-
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
NCT01474135 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
NCT01696383 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy of Changing to DUOTRAV® From Prior Therapy
NCT01327599 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension
NCT00788541 ·Status: TERMINATED ·Phase: PHASE2
-
Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
NCT03067415 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
NCT00672997 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
NCT00051181 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
NCT00288951 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
NCT00293761 ·Status: COMPLETED ·Phase: PHASE3